Perphenazine Uses, Dosage, Side Effects and Interactions
Trilafon
Trilafon is a perphenazine brand from before 1982. The FDA now lists it as discontinued; generic perphenazine is still listed.
Perphenazine is an older antipsychotic (a phenothiazine) used to treat schizophrenia and to control severe nausea and vomiting in adults.
Quick links
Ask Anything About PerphenazineType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Perphenazine in Short
- Drug class Phenothiazine How the FDA classifies it
What it treatsPerphenazine tablets treat schizophrenia. They also control severe nausea and vomiting in adults. It has not been shown to work for behavioral complications in people with intellectual disability (called “mental retardation” in the label).
- How you get it Prescription only
- Comes asTablet (by mouth)
- The FDA’s strongest warningBoxed warning The FDA’s most serious alert. Read what it says
- Supplements and herbs145 interact 5 major, 106 moderate and 34 minor
- What pharmacies pay
- Generic$0.13 to $0.36 a tablet
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
The Pharmacist’s Take
Perphenazine (Trilafon) is an older phenothiazine antipsychotic for schizophrenia and severe nausea and vomiting in adults, a standby since the late 1950s with FDA-approved generics listed, though newer antipsychotics are prescribed more often. Most people manage it, though early drowsiness, dry mouth, constipation and lightheadedness on standing are common. It carries a boxed warning for higher risk of death in older adults with dementia-related psychosis, a use it is not approved for. Regular check-ins keep the dose low, since longer use raises the risk of tardive dyskinesia, repeated face, mouth or tongue movements that can be permanent.
Key Takeaways From the HelloPharmacist Team
- Take it by mouth, usually a few times a day, and expect your prescriber to lower the dose once symptoms are controlled.
- Expect drowsiness in the first week or two, so skip alcohol and hold off driving until you know how it affects you.
- Get help fast for neck or jaw spasms or throat tightness in the first days, or fever with stiff muscles and confusion anytime.
- Tell your prescriber if you take fluoxetine, sertraline, paroxetine or a tricyclic antidepressant, since these can raise perphenazine levels.
FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Perphenazine.
Older adults with dementia-related psychosis who take antipsychotics like perphenazine have a higher risk of death. In trials of about 10 weeks, about 4.5% of drug-treated patients died, compared with about 2.6% on placebo.
Most deaths were heart-related (such as heart failure or sudden death) or infections (such as pneumonia). Perphenazine is not approved to treat dementia-related psychosis. If you care for someone with dementia who takes it, talk with their prescriber.
Patient Information Guide for Perphenazine
What It’s Used For
Perphenazine is used for these conditions in adults:
- Schizophrenia
- Severe nausea and vomiting
It has not been shown effective for behavioral complications in people with intellectual disability. Perphenazine tablets (oral, including the film-coated tablets) carry these uses.
How It Works
Perphenazine acts at all levels of the central nervous system, especially the hypothalamus. The exact site and mechanism behind its therapeutic effect are not known.
Drug Class
Drug Class
- Phenothiazine
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)- Phenothiazine
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)None listed for Perphenazine in the FDA’s index.
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Perphenazine in the FDA’s index.
From our Patient Information GuidePerphenazine acts at all levels of the central nervous system, especially the hypothalamus. The exact site and mechanism behind its therapeutic effect are not known. Read How Perphenazine Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)- Phenothiazines
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Phenothiazines with piperazine structure
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
Perphenazine tablets are taken by mouth. Your prescriber individualizes the dose and aims for the lowest dose that works, since movement-related side effects increase with higher doses.
- Dosing for schizophrenia is often several times a day at first, then lowered to the minimum effective amount.
- For nausea and vomiting, the daily amount is split into divided doses, and early reduction is desirable.
- Older adults usually start lower.
- A dose may be taken at bedtime if needed.
Follow your prescriber and the pharmacy label.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Schizophrenia
Moderately disturbed adults not in a hospital · Starting dose Starting dose 4 to 8 mg three times a day
- 4 to 8 mg t.i.d. initially
- Reduce as soon as possible to minimum effective dosage
Adults in a hospital Usual dose 8 to 16 mg two to four times a day Highest dose 64 mg a day
- 8 to 16 mg b.i.d. to q.i.d.
b.i.d. means twice a day.
Severe nausea and vomiting
For adults
Usual dose 8 to 16 mg a day in divided doses
- 24 mg occasionally may be necessary, early dosage reduction is desirable
Other Doses
Older adults Geriatric dosages have not been established; initiation of lower dosages is recommended. Optimal effect may require lower doses for a longer duration
Good to know
Plasma concentrations per daily ingested dose increase with increasing age
Side Effects
Common effects include:
Common side effects
- Drowsiness, especially in the first week or two
- Dizziness or lightheadedness when standing up
- Dry mouth
- Constipation
- Blurred vision
- Nasal congestion
- Restlessness or muscle stiffness (extrapyramidal symptoms)
- Increased appetite and weight gain
- Dizziness and low blood pressure on standing
- Restlessness, stiffness or tremor-like movement problems
When to get medical help
- Call your doctor right away if you have fever, stiff muscles, confusion, irregular pulse or blood pressure, or heavy sweating. These can be signs of neuroleptic malignant syndrome, which can be fatal.
- Tell your doctor about repeated or unusual movements of the tongue, face, mouth or jaw. These can be tardive dyskinesia, which may be permanent.
- Get help for neck spasms, throat tightness, trouble swallowing or breathing, or tongue protrusion (dystonia), which can occur in the first few days.
- Report a sudden sore throat or signs of infection, especially in weeks 4 to 10. These can signal a serious drop in white blood cells.
- Report yellowing of the skin or eyes (jaundice), usually seen in weeks 2 to 4.
- Seek care for seizures, fainting, or a very fast, slow or irregular heartbeat.
- Tell your doctor about vision changes or skin pigment changes during long-term use.
- Get emergency help for severe constipation or belly swelling, which can signal a bowel blockage (adynamic ileus).
Warnings and Precautions
- Higher risk of death in older adults with dementia-related psychosis (boxed warning).
- Tardive dyskinesia (uncontrolled movements) can be permanent.
- Neuroleptic malignant syndrome is a rare, potentially fatal reaction.
- Low white blood cell counts, mostly in weeks 4 to 10.
- Falls and injuries from drowsiness and low blood pressure.
- Impaired driving and machinery use.
- Can lower the seizure threshold.
Interactions
These can change how perphenazine works or how safe it is:
- Alcohol, barbiturates, narcotics, pain medicines and antihistamines in large amounts: added sedation, so avoid.
- Tricyclic antidepressants, fluoxetine, sertraline and paroxetine: can raise perphenazine levels, so doses may need lowering.
- Anticonvulsants: the anticonvulsant dose may need to increase.
- Epinephrine: its effect is blocked, so it should not be used for low blood pressure.
Interactions Listed in the FDA-Approved Label
From the Perphenazine prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Drugs that inhibit P450 2D6, such as tricyclic antidepressants and selective serotonin reuptake inhibitors (fluoxetine, sertraline, paroxetine)What happensThey may acutely increase plasma concentrations of antipsychotics.What to doClose monitoring is essential and dose reduction may become necessary to avoid toxicity; lower doses than usually prescribed for either the antipsychotic or the other drug may be required.
-
Poor P450 2D6 metabolizers (about 10% of the Caucasian population)What happensThey have higher plasma concentrations of antipsychotic drugs at usual doses, which may correlate with side effects.What to doProspective phenotyping of elderly patients before antipsychotic treatment may identify those at risk for adverse events.
Read the label’s full interactions text
Drug Interactions Metabolism of a number of medications, including antipsychotics, antidepressants, ß-blockers, and antiarrhythmics, occurs through the cytochrome P450 2D6 isoenzyme (debrisoquine hydroxylase). Approximately 10% of the Caucasian population has reduced activity of this enzyme, so-called “poor” metabolizers. Among other populations the prevalence is not known. Poor metabolizers demonstrate higher plasma concentrations of antipsychotic drugs at usual doses, which may correlate with emergence of side effects. In one study of 45 elderly patients suffering from dementia treated with perphenazine, the 5 patients who were prospectively identified as poor P450 2D6 metabolizers had reported significantly greater side effects during the first 10 days of treatment than the 40 extensive metabolizers, following which the groups tended to converge. Prospective phenotyping of elderly patients prior to antipsychotic treatment may identify those at risk for adverse events. The concomitant administration of other drugs that inhibit the activity of P450 2D6 may acutely increase plasma concentrations of antipsychotics. Among these are tricyclic antidepressants and selective serotonin reuptake inhibitors, e.g., fluoxetine, sertraline and paroxetine. When prescribing these drugs to patients already receiving antipsychotic therapy, close monitoring is essential and dose reduction may become necessary to avoid toxicity. Lower doses than usually prescribed for either the antipsychotic or the other drug may be required.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Do not use if comatose or very hard to wake, or if you have blood disorders, bone marrow depression, or liver damage.
- Do not use if you are allergic to perphenazine or related drugs.
- Do not use with suspected or established subcortical brain damage.
- Use caution with seizure disorders, alcohol withdrawal, depression, mitral insufficiency or pheochromocytoma.
- Older adults need lower starting doses and are at higher risk of tardive dyskinesia.
- Not recommended under age 12.
- Pregnancy and breastfeeding: safety is not established, so benefits must be weighed against risks.
Overdose
Overdose can cause stupor or coma, severe movement side effects, and serious heart rhythm problems. Seizures can occur in children. Get emergency treatment right away and consider calling a poison center. There is no specific antidote, and care is supportive with heart monitoring.
Half-Life and How Your Body Processes It
After a tablet is taken by mouth, blood levels peak in about 1 to 3 hours. The half-life is about 9 to 12 hours, and steady levels are reached within about 72 hours of regular dosing. The liver breaks it down extensively, partly through the CYP2D6 enzyme. People with low CYP2D6 activity clear it more slowly and have higher levels.
Storage
Store at 20° to 25°C (68° to 77°F) .
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Supplements and Herbs That Interact With Perphenazine
From the licensed clinical database we use, rolled up per supplement, most serious first.145 supplements and herbal products have documented interactions with Perphenazine in the licensed clinical database we use.
Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.
- 5Major
- 106Moderate
- 34Minor
- ACTIVATED CHARCOALMajor
- HENBANEMajor
- INDIAN SNAKEROOTMajor
- RAUVOLFIA VOMITORIAMajor
- SCOPOLIAMajor
- 1,3-DMAAModerate
- ACACIA RIGIDULAModerate
- ACTIVE HEXOSE CORRELATED COMPOUND (AHCC)Moderate
Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Perphenazine: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Perphenazine — the kind of thing our pharmacy team would talk through with you at the counter.
What is perphenazine used for?
Can I drink alcohol or drive while taking perphenazine?
What side effects should I expect?
When should I call my doctor right away?
Is perphenazine safe for older adults?
Can I take perphenazine if I'm pregnant or breastfeeding?
Is perphenazine available over the counter?
When was perphenazine first available?
Who makes perphenazine?
What is the brand name of perphenazine?
What is the generic name of Trilafon?
What drug class is perphenazine?
Is there a generic version of perphenazine?
What strengths does perphenazine come in?
How much does perphenazine cost?
Is there a perphenazine shortage?
Where can I read the perphenazine prescribing information (package insert)?
Is perphenazine gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Perphenazine
Skip the scrolling. Ask in your own words and get an answer from Perphenazine’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Perphenazine’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Perphenazine on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, usually within a day.Perphenazine Forms and Strengths (How It Comes)
Perphenazine comes in 1 dose form, the tablet. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Perphenazine inactive ingredients by manufacturer.
Tablet
How this form is used
- Perphenazine tablets are used to treat schizophrenia.
- Perphenazine tablets are used to control severe nausea and vomiting in adults.
- Perphenazine tablets are taken by mouth, with the dose individualized to your condition and response.
- Perphenazine tablets may be dosed before bedtime if needed.
- Perphenazine tablets in older adults are generally started at lower doses.
Perphenazine on the U.S. Market: Products, Makers and Brands
How Perphenazine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
16 companies list 73 Perphenazine product records with the FDA, mostly as tablet; the earliest marketing or approval year on record is 1957.
Also listed with the FDA, not a patient dose form: Unfinished tablet, film coated (4) · Powder (3) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Perphenazine Is Used (Medicaid Data)
How many Perphenazine prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Perphenazine prescribed? Of the 1,682 medications we measure, Perphenazine ranks #587 by Medicaid prescriptions — more than 65% of them.
Utilization by Perphenazine product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
perphenazine 8 MG Oral Tablet Most dispensed
9 of 46 listed NDCs had Medicaid claims. RxNorm 198078
perphenazine 4 MG Oral Tablet
9 of 43 listed NDCs had Medicaid claims. RxNorm 198077
perphenazine 2 MG Oral Tablet
9 of 43 listed NDCs had Medicaid claims. RxNorm 198076
perphenazine 16 MG Oral Tablet
8 of 45 listed NDCs had Medicaid claims. RxNorm 198075
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 35 of the 177 listed Perphenazine NDCs had Medicaid claims.
Compare Perphenazine Products
A representative set of FDA-listed product records for Perphenazine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Tablet | ||||
| 2 mg | Oral | Actavis Pharma, Inc. | ANDA | View NDC → |
| 4 mg | Oral | Actavis Pharma, Inc. | ANDA | View NDC → |
| 8 mg | Oral | Actavis Pharma, Inc. | ANDA | View NDC → |
| 16 mg | Oral | Actavis Pharma, Inc. | ANDA | View NDC → |
| 4 mg | Oral | American Health Packaging | ANDA | View NDC → |
| 8 mg | Oral | American Health Packaging | ANDA | View NDC → |
| 2 mg | Oral | Bryant Ranch Prepack × 3 listings | ANDA | View NDC → |
| 4 mg | Oral | Bryant Ranch Prepack × 4 listings | ANDA | View NDC → |
| 8 mg | Oral | Bryant Ranch Prepack × 5 listings | ANDA | View NDC → |
| 16 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 4 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 2 mg | Oral | Endo USA, Inc. | ANDA | View NDC → |
| 4 mg | Oral | Endo USA, Inc. | ANDA | View NDC → |
| 8 mg | Oral | Endo USA, Inc. | ANDA | View NDC → |
| 16 mg | Oral | Endo USA, Inc. | ANDA | View NDC → |
| 2 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 4 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 8 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 16 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 2 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 4 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 8 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 16 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 2 mg | Oral | Macleods Pharmaceuticals Limited | ANDA | View NDC → |
| 4 mg | Oral | Macleods Pharmaceuticals Limited | ANDA | View NDC → |
| 8 mg | Oral | Macleods Pharmaceuticals Limited | ANDA | View NDC → |
| 16 mg | Oral | Macleods Pharmaceuticals Limited | ANDA | View NDC → |
| 2 mg | Oral | Major Pharmaceuticals | ANDA | View NDC → |
| 4 mg | Oral | Major Pharmaceuticals | ANDA | View NDC → |
| 8 mg | Oral | Major Pharmaceuticals | ANDA | View NDC → |
| 2 mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| 4 mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| 8 mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| 16 mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| 2 mg | Oral | Remedyrepack Inc. × 2 listings | ANDA | View NDC → |
| 4 mg | Oral | Remedyrepack Inc. × 2 listings | ANDA | View NDC → |
| 8 mg | Oral | Remedyrepack Inc. × 2 listings | ANDA | View NDC → |
| 16 mg | Oral | Remedyrepack Inc. × 3 listings | ANDA | View NDC → |
| 2 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 4 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 8 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 16 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 2 mg | Oral | Sandoz Inc | ANDA | View NDC → |
| 4 mg | Oral | Sandoz Inc | ANDA | View NDC → |
| 8 mg | Oral | Sandoz Inc | ANDA | View NDC → |
| 16 mg | Oral | Sandoz Inc | ANDA | View NDC → |
| 2 mg | Oral | Wilshire Pharmaceuticals, Inc. | ANDA | View NDC → |
| 4 mg | Oral | Wilshire Pharmaceuticals, Inc. | ANDA | View NDC → |
| 8 mg | Oral | Wilshire Pharmaceuticals, Inc. | ANDA | View NDC → |
| 16 mg | Oral | Wilshire Pharmaceuticals, Inc. | ANDA | View NDC → |
| 2 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| 4 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| 8 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| 16 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| 2 mg | Oral | Zydus Pharmaceuticals (USA) Inc. | ANDA | View NDC → |
| 4 mg | Oral | Zydus Pharmaceuticals (USA) Inc. | ANDA | View NDC → |
| 8 mg | Oral | Zydus Pharmaceuticals (USA) Inc. | ANDA | View NDC → |
| 16 mg | Oral | Zydus Pharmaceuticals (USA) Inc. | ANDA | View NDC → |
Showing 73 of 73 products — FDA National Drug Code Directory. See every product, package size and price: browse all 73 Perphenazine NDCs →
Perphenazine Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Perphenazine — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Perphenazine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Perphenazine FDA Approval History
How Perphenazine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Perphenazine Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Perphenazine recalls since July 2021.
✅No Perphenazine recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Perphenazine in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 2
- Strengths
- 6
- Forms in current FDA listings
- 1 of 2
RxCUI 8076 -
Dose form (SCDF) Oral SolutionNo current FDA listing
RxCUI 373296Its 2 strengths (SCD)-
0.4 mg/mL
RxCUI 108874 -
0.8 mg/mL
RxCUI 108875
-
0.4 mg/mL
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Perphenazine Supply and Shortage Status
Whether Perphenazine is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Perphenazine Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Perphenazine: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.
How the Pharmacy Price Has Changed
Pick a strength to see how its price has changed since Nov 2023.
For the generic 2 mg tablet, pharmacies paid an average of $0.156 per tablet as of Nov 18, 2026, down 15% from $0.183 a year earlier.
- What pharmacies pay now
- $0.156
- per tablet, as of Nov 18, 2026
- Last 4 weeks
- Down 9.3%
- from $0.172 on Oct 21, 2026
- Last 12 months
- Down 15%
- from $0.183 on Nov 19, 2025
- Lowest and highest since Nov 2023
- $0.147 to $0.238
- per tablet
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $0.156 |
| Oct 2026 | $0.172 |
| Sep 2026 | $0.197 |
| Aug 2026 | $0.206 |
| Jul 2026 | $0.207 |
| Jun 2026 | $0.195 |
| May 2026 | $0.185 |
| Apr 2026 | $0.189 |
| Mar 2026 | $0.200 |
| Feb 2026 | $0.197 |
| Jan 2026 | $0.184 |
| Dec 2025 | $0.161 |
| Nov 2025 | $0.183 |
| Oct 2025 | $0.193 |
| Sep 2025 | $0.217 |
| Aug 2025 | $0.192 |
| Jul 2025 | $0.180 |
| Jun 2025 | $0.187 |
| May 2025 | $0.204 |
| Apr 2025 | $0.202 |
| Mar 2025 | $0.177 |
| Feb 2025 | $0.162 |
| Jan 2025 | $0.178 |
| Dec 2024 | $0.198 |
| Nov 2024 | $0.220 |
| Oct 2024 | $0.203 |
| Sep 2024 | $0.212 |
| Aug 2024 | $0.166 |
| Jul 2024 | $0.190 |
| Jun 2024 | $0.173 |
| May 2024 | $0.166 |
| Apr 2024 | $0.151 |
| Mar 2024 | $0.238 |
| Feb 2024 | $0.170 |
| Jan 2024 | $0.147 |
| Dec 2023 | $0.217 |
| Nov 2023 | $0.219 |
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Tablet · Oral | 2 mg | Generic | $0.156 per tablet | NDC details & price history |
| Tablet · Oral | 4 mg | Generic | $0.169 per tablet | NDC details & price history |
| Tablet · Oral | 8 mg | Generic | $0.129 per tablet | NDC details & price history |
| Tablet · Oral | 16 mg | Generic | $0.356 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Perphenazine Brand Names
Perphenazine has one brand name on record: Trilafon. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Perphenazine: Manufacturers and Labelers
16 companies list Perphenazine products with the FDA. By number of product records, the largest are Bryant Ranch Prepack, Remedyrepack Inc., Actavis Pharma, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Perphenazine Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Rising Pharma Holdings, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →